MLICM
MTEM

Metropolitan Life Insurance Company (MetLife)’s Molecular Templates, Inc. MTEM Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-105
Closed -$19.9K – 2919
2021
Q1 		$19.9K Buy
+105
New +$18.4K ﹤0.01% 2569
2020
Q4 		– Sell
-544
Closed -$89K – 2583
2020
Q3 		$89K Hold
544
– – ﹤0.01% 2284
2020
Q2 		$112K Buy
544
+146
+37% +$33.9K ﹤0.01% 2186
2020
Q1 		$79.3K Buy
+398
New +$87.1K ﹤0.01% 2176
2015
Q4 		– Sell
-250
Closed -$168K – 2642
2015
Q3 		$168K Buy
250
+113
+82% +$80.4K ﹤0.01% 2401
2015
Q2 		$92K Sell
137
-141
-51% -$93.2K ﹤0.01% 2615
2015
Q1 		$186K Buy
+278
New +$183K ﹤0.01% 2093
2014
Q4 		– Sell
-238
Closed -$142K – 2678
2014
Q3 		$142K Buy
238
+16
+7% +$11.1K ﹤0.01% 2561
2014
Q2 		$145K Sell
222
-2
-0.9% -$1.32K ﹤0.01% 2654
2014
Q1 		$176K Sell
224
-13
-5% -$10.6K ﹤0.01% 2546
2013
Q4 		$183K Buy
237
+12
+5% +$9.05K ﹤0.01% 2536
2013
Q3 		$173K Sell
225
-2
-0.9% -$1.64K ﹤0.01% 2525
2013
Q2 		$197K Buy
+227
New +$192K ﹤0.01% 2373

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s MTEM Position: Q2 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Molecular Templates, Inc. (MTEM) in Q2 2021, closing a stake of 105 shares — an estimated $19.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MTEM in Q2 2013 and held it in 13 quarters. The position peaked at $197K in Q2 2013. 89 funds tracked by Wall St. Rank hold MTEM as of Q2 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Molecular Templates, Inc. position as of Q2 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 105 Molecular Templates, Inc. shares in Q2 2021, an estimated $19.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 13 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Molecular Templates, Inc. position peaked at $197K in Q2 2013.
  • 89 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2021, filed 16 Aug 2021.